Zora Biosciences Oy

Zora Biosciences Oy is an SME in Espoo, Finland that has taken part in 7 EU-funded projects since 2008, receiving €4.4M in EU funding.

EU funding received€4.4M
EU projects7
As coordinator0
Running now1
First EU project2008
Latest project2020
CountryFinland
EU registration (PIC)999555028
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Zora Biosciences Oy's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€2.8M · 5 projects
  • Horizon 2020€1.6M · 2 projects

Projects

7 EU-funded projects, newest first. Each links to the official record.

  • CoroPreventionPartner

    Personalized Prevention for Coronary Heart Disease

    Horizon 2020 · 2020–2026 · Project on CORDIS ↗

    €1.2Mtheir share
  • TAXINOMISISPartner

    A multidisciplinary approach for the stratification of patients with carotid artery disease

    Horizon 2020 · 2018–2023 · Project on CORDIS ↗

    €399ktheir share
  • Athero-FluxPartner

    Targeting novel lipid pathways for treatment of cardiovascular disease

    FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗

    €973ktheir share
  • RISKYCADPartner

    Personalized diagnostics and treatment of high risk coronary artery disease patients.

    FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗

    €710ktheir share
  • ATHEROREMOPartner

    European Collaborative Project on Inflamation and Vascular Wall Remodelling in Atherosclerosis

    FP7 (2007 to 2013) · 2008–2013 · Project on CORDIS ↗

    €569ktheir share
  • LIPIDOMICNETPartner

    Lipid droplets as dynamic organelles of fat deposition and release: Translational research towards human disease

    FP7 (2007 to 2013) · 2008–2012 · Project on CORDIS ↗

    €300ktheir share
  • DIAPREPPPartner

    DIAbetes type 1 PRediction, Early Pathogenesis and Prevention

    FP7 (2007 to 2013) · 2008–2011 · Project on CORDIS ↗

    €205ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • RNA
  • arteriosclerosis
  • diabetes
  • genetics
  • immunisation
  • lab on a chip
  • laboratory samples analysis
  • lipids
  • mass spectrometry
  • molecular evolution
  • mortality
  • nucleotides
  • pathology
  • pharmaceutical drugs

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime